Carly Kenselaar

Stock Analyst

(n/a)

# 4,648

Out of 4,648 analysts

5

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	TVTX Travere Therapeutics	Maintains: Buy	$23 → $19	$18.10	+4.97%	4	Sep 27, 2024
	KRYS Krystal Biotech	Initiates: Buy	$160	$170.85	-6.35%	1	Oct 12, 2023

Travere Therapeutics

Sep 27, 2024

Maintains: Buy

Price Target: $23 → $19

Current: $18.10

Upside: +4.97%

Krystal Biotech

Oct 12, 2023

Initiates: Buy

Price Target: $160

Current: $170.85

Upside: -6.35%